These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6070358)

  • 21. The response of children to a reduced dose of measles vaccine given with and without other vaccines. (pilot study).
    Cruickshank JG; Dalton H; Lochrie G; Campbell I
    Cent Afr J Med; 1974 Oct; 20(10):201-2. PubMed ID: 4426084
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4-6 years old.
    Techasena W; Wongwacharapiboon P; Terawanich S; Pattamadilok S
    J Med Assoc Thai; 2011 Mar; 94(3):309-15. PubMed ID: 21560838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the simultaneous use of live-virus vaccines, for example measles-polio vaccine].
    Böthig B; Gerike E; Starke G; Giesecke H
    Rev Roum Virol (1972); 1974; 25(1):15-21. PubMed ID: 4410266
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
    [No Abstract]   [Full Text] [Related]  

  • 27. [Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].
    Trier H; Rønne T
    Ugeskr Laeger; 1992 Jul; 154(29):2008-13. PubMed ID: 1509566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

  • 29. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled epidemiological study of live measles vaccines in Poland.
    Polish Measles Vaccination Committee
    Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
    Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
    [No Abstract]   [Full Text] [Related]  

  • 34. [A study of the serological response of Sudanese children to three associated immunizations (measles, tetanus, meningococcal A meningitis) (author's transl)].
    Lapeyssonnie L; Omer IA; Nicolas A; Roumiantzeff M
    Med Trop (Mars); 1979; 39(1):71-9. PubMed ID: 110997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 36. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the vaccination of a mixture of inactivated and measles vaccines. 2. Investigation on occurrence of measles in Utsunomiya City].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):170-4. PubMed ID: 5065658
    [No Abstract]   [Full Text] [Related]  

  • 38. Live, attenuated mumps-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.